• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Cardiovascular benefits of intensive systolic blood pressure control may outweigh risks of chronic kidney disease events

byEvelyn NguyenandDeepti Shroff Karhade
September 5, 2017
in Cardiology, Chronic Disease, Endocrinology, Nephrology, Neurology, Public Health
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. The benefits of intensive systolic blood pressure (SBP) control to cardiovascular and all-cause mortality may outweigh the increased risk of incident chronic kidney disease (CKD) events.

2. For each cardiovascular event or death from any cause prevented during the study, 1.2 incident CKD events were noted, which may be of concern to patients and providers who consider incident CKD to be of greater importance than CVD events or death.

Evidence Rating Level: 1 (Excellent)

Study Rundown: An estimated 1.3 billion adults worldwide have hypertension, which is a chief risk factor for events relating to cardiovascular disease (CVD), end-stage renal disease (ESRD), and death from any cause. The SPRINT (Systolic Blood Pressure Intervention Trial) studied the effects of intensive versus standard (target <120 mm Hg and <140 mm Hg, respectively) SBP control. The study showed evidence that intensive therapy significantly decreased CVD events and all-cause death. However, in people who did not have kidney disease at baseline, those in the intensive therapy group had a 3.5 times higher risk of incident CKD. This secondary analysis of the SPRINT sought to examine the cardiovascular and kidney effects of intensive SBP control and to compare the benefits and risks of such therapy. Researchers found that although the risk of incident CKD events was increased by intensive SBP control, the benefits to cardiovascular and all-cause mortality outweighed the risks. For each cardiovascular event or death from any cause prevented during the study, 1.2 incident CKD events were noted, which may be of concern to patients and providers who consider incident CKD to be of greater importance than CVD events or death.

A strength of the study is random assignment of 6 662 qualifying patients from the SPRINT study to each study group. A limitation of the study is the lack of long-term data.

Click to read the study, published today in Annals of Internal Medicine

Relevant Reading: A randomized trial of intensive versus standard blood-pressure control

RELATED REPORTS

#VisualAbstract: Dapagliflozin associated with reduced risk of cardiovascular and kidney outcomes irrespective of background use of cardiovascular medications

#VisualAbstract: Oral methylprednisolone may reduce risk of progressive renal failure in patients with IgA nephropathy: TESTING Trial

Mediterranean diet superior to low-fat diet in secondary prevention of cardiovascular events

In-Depth [randomized controlled trial]: This study is a secondary analysis of incident CKD and incident albuminuria performed in a subgroup of SPRINT (a randomized, controlled, open-label trial) participants without baseline CKD. Participants were ≥50 years of age, had a SBP of 130 to 180 mm Hg, and had a heightened risk for CVD. Recruitment took place between November 2010 and March 2013. Participants were randomly assigned to an intensive or standard SBP control group. In the intensive group, 3 326 and 3 295 participants were analyzed for CVD and CKD outcomes, respectively. In the standard group, 3 336 and 3 295 corresponding participants were analyzed. Researchers found that at 6 months, there was a difference in adjusted mean estimated glomerular filtration rate (eGFR) of –3.32 mL/min/1.73 m2 (95%CI, –3.90 to –2.74 mL/min/1.73 m2) between the intensive and standard SBP lowering groups. At 18 months, the difference was –4.50 mL/min/1.73 m2 (CI, –5.16 to –3.85 mL/min/1.73 m2), with subsequent rates remaining relatively stable. At a 3-year follow-up, an incident CKD event occurred in 3.7% and 1.0% of participants of the intensive and standard groups, respectively. Also at 3-year follow-up, the composite of death or cardiovascular events were 4.9% and 7.1% of participants of the intensive and standard groups, respectively.

Image: PD

©2017 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: blood pressurecardiovascular riskhypertensionrenal failure
Previous Post

Re-analysis of evidence suggests that PSA screening significantly reduces the risk for death from prostate cancer

Next Post

Antibiotic prescribing rates in pediatric emergency departments vary by race and ethnicity

RelatedReports

#VisualAbstract: Dapagliflozin associated with reduced risk of cardiovascular and kidney outcomes irrespective of background use of cardiovascular medications
StudyGraphics

#VisualAbstract: Dapagliflozin associated with reduced risk of cardiovascular and kidney outcomes irrespective of background use of cardiovascular medications

August 10, 2022
#VisualAbstract: Oral methylprednisolone may reduce risk of progressive renal failure in patients with IgA nephropathy: TESTING Trial
StudyGraphics

#VisualAbstract: Oral methylprednisolone may reduce risk of progressive renal failure in patients with IgA nephropathy: TESTING Trial

June 2, 2022
FDA-approved weight loss medications associated with weight loss at one year
Cardiology

Mediterranean diet superior to low-fat diet in secondary prevention of cardiovascular events

May 25, 2022
Prenatal antidepressant exposure may increase risk of poor motor development
Cardiology

Treating mild chronic hypertension associated with better pregnancy outcome

May 13, 2022
Next Post
Implementation of pneumococcal vaccine programs linked to decreased antibiotic prescription

Antibiotic prescribing rates in pediatric emergency departments vary by race and ethnicity

Development of a risk index for colorectal cancer screening

Physician notification increases patient participation in colorectal cancer screening

Live attenuated vaccine less effective in recent influenza season

Rapid tests linked to quicker and more accurate results for influenza diagnosis than traditional tests

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Subthreshold micropulse laser is equivalent to standard laser for treating diabetic macular edema
  • Gadolinium-containing contrast associated with nephrogenic fibrosing dermopathy and systemic fibrosis [Classics Series]
  • Study supports continued use of amoxicillin as first-line therapy for pediatric ear infections
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.